Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10407299 | 0.83 | KDM4E (0.36) | KDM4EPKMLMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL10408137 | 0.78 | PKM (0.45) | KDM4EPKMLMNAL3MBTL1MAPK1 | |
| SCHEMBL9822171 | 0.73 | PKM (0.35) | KDM4EPKMLMNAMAPK1ALDH1A1 | |
| SCHEMBL10407380 | 0.72 | POLB (0.39) | KDM4EPKMLMNAL3MBTL1MAPK1 | |
| SCHEMBL9822417 | 0.70 | LMNA (0.35) | KDM4EPKMLMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL9822097 | 0.70 | PKM (0.35) | PKMLMNA | |
| SCHEMBL10407269 | 0.68 | LMNA (0.60) | PKMLMNASMN1; SMN2L3MBTL1MAPK1 | |
| SCHEMBL10407681 | 0.68 | ALDH1A1 (0.39) | ALDH1A1KMT2A | |
| SCHEMBL10397427 | 0.68 | LMNA (0.33) | KDM4EPKMLMNASMN1; SMN2MAPK1 | |
| SCHEMBL9822277 | 0.68 | LMNA (0.39) | KDM4EPKMLMNAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0254495-A2 | Beta-Lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same | SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) | 1988-01-27 | — | — | EP | disclosed |